Capital Group Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Buy
5,951
+162
+3% +$57.8K 0.36% 77
2025
Q4
$1.89M Sell
5,789
-5,943
-51% -$1.89M 0.31% 80
2025
Q3
$3.31M Buy
11,732
+5,666
+93% +$1.64M 0.55% 51
2025
Q2
$1.69M Buy
6,066
+169
+3% +$47.9K 0.3% 83
2025
Q1
$1.84M Buy
+5,897
New +$1.74M 0.38% 75
2024
Q2
Sell
-4,872
Closed -$1.39M 142
2024
Q1
$1.39M Buy
+4,872
New +$1.43M 0.25% 104

Other funds holding AMGN

Capital Group Investment Management's AMGN Position: Q1 2026 in Review

Capital Group Investment Management increased its Amgen (AMGN) stake by 2.8% in Q1 2026, buying an estimated $57.8K and bringing the position to 5,951 shares worth $2.09M. The position accounts for 0.36% of the portfolio, ranked #77.

Capital Group Investment Management first reported a position in AMGN in Q1 2024 and has held it in 6 quarters since. The position peaked at $3.31M in Q3 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capital Group Investment Management held 5,951 shares of Amgen worth $2.09M as of Q1 2026.
  • Capital Group Investment Management bought 162 Amgen shares in Q1 2026, an estimated $57.8K.
  • Amgen made up 0.36% of Capital Group Investment Management's portfolio in Q1 2026, its #77 holding.
  • Capital Group Investment Management first reported a position in Amgen in Q1 2024 and has held it in 6 quarters since.
  • Capital Group Investment Management's Amgen position peaked at $3.31M in Q3 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capital Group Investment Management's 13F filing for Q1 2026, filed 13 May 2026.